October 27, 2017
Sawai Pharmaceutical and Pfizer Japan said on October 25 that their generic versions of the cholesterol fighter Crestor (rosuvastatin) have won approval for familial hypercholesterolemia (FH), putting them on a level playing field with the originator before their anticipated listing...read more